WHO ICTRP trial
A 2-part Phase I study to evaluate the safety, tolerability, pharmacokinetics…
ACTRN12624001294549 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12624001294549 |
|---|---|
| Public title | A 2-part Phase I study to evaluate the safety, tolerability, pharmacokinetics and food effects of AXN-027 |
| Scientific title | A 2-part Phase I study to evaluate the safety, tolerability, pharmacokinetics including food effect and relative bioavailability of capsules vs tablets, and pharmacodynamic effects of AXN-027 in healthy adult volunteers |
| Primary sponsor | Axonis Australia Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Epilepsy; Epilepsy;Neurological - Epilepsy |
| Interventions | Participants will be confined at the site during the dosing period where dosing will be done via direct supervision and they can only participate in one of the following cohorts: - Part 1 cohorts 1, 2, 4, 5 (oral capsule): Screening/… |
| Registration date | Oct 24, 2024 |
| Target size | 69 |
| Secondary IDs | AXN-027-1001 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: